OncoSil Medical Limited announced the appointment of former Sirtex Group Chief Commercial Officer Nigel Lange as EMEA President. As EMEA President, OncoSil Medical, Mr. Nigel Lange will be responsible for further building the Company's commercial infrastructure on the ground in Europe. He will be the accountable executive for developing and executing the company's European business plan and will report directly to Daniel Kenny, OncoSil Medical CEO. He will have full P&L responsibility and be responsible for hiring and management of all European sales and marketing professionals. Most recently, he served as Group Chief Commercial Officer of Sirtex Medical from 2017 to 2018 where he was responsible for all commercial aspects of the business and early 2017, Nigel served as Interim Group CEO assuming 100% responsibility for the management of all business units and operations globally.